Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Momordica charantia (leaf)
Feuilles de vigne tropicale contenant des composés antidiabétiques similaires à ceux du fruit de melon amer.
Bitter gourd leaf (Momordica charantia) is a tropical vine leaf traditionally used in Ayurvedic, Philippine, and African medicine for diabetes, digestive issues, and parasitic infections. Its active compounds—charantin, momordicin, polypeptide-p, vicine, and beta-carotene—contribute to hypoglycemic, antiparasitic, and antiviral effects. Evidence is limited (Level C), but preliminary studies support its role in blood sugar management and as an adjunct therapy.
Charantin and momordicin activate AMPK and enhance GLUT4 translocation, increasing cellular glucose uptake. Polypeptide-p exhibits insulin-like activity by binding to insulin receptors, while alpha-glucosidase inhibition reduces postprandial hyperglycemia. Antiparasitic effects are attributed to triterpenoid disruption of parasite cell membranes, and antiviral activity involves inhibition of viral replication via NF-κB and MAPK pathway modulation.
Feuilles de vigne tropicale contenant des composés antidiabétiques similaires à ceux du fruit de melon amer.
Bitter gourd leaf (Momordica charantia) is a tropical vine leaf traditionally used in Ayurvedic, Philippine, and African medicine for diabetes, digestive issues, and parasitic infections. Its active compounds—charantin, momordicin, polypeptide-p, vicine, and beta-carotene—contribute to hypoglycemic, antiparasitic, and antiviral effects. Evidence is limited (Level C), but preliminary studies support its role in blood sugar management and as an adjunct therapy.
Charantin and momordicin activate AMPK and enhance GLUT4 translocation, increasing cellular glucose uptake. Polypeptide-p exhibits insulin-like activity by binding to insulin receptors, while alpha-glucosidase inhibition reduces postprandial hyperglycemia. Antiparasitic effects are attributed to triterpenoid disruption of parasite cell membranes, and antiviral activity involves inhibition of viral replication via NF-κB and MAPK pathway modulation.